Where it is registered
Each register and historical list with its number of registrations and a few of them.
United States
FDA · 13 registrations
- Chlorothiazide Sodium500MG BASE/VIAL · injectable · Am Regent
- Diuril250MG/5ML · suspension · Salix Pharms
- Chlorothiazide250MG, 500MG · tablet · Watson Labs
- Diuril250MG, 500MG · tablet · Rising
Canada
Health Canada · 2 registrations
New Zealand
PHARMAC (NZ funding schedule) · 1 registration
At a glance
- Registers
- 3
- Registrations
- 16
- With their own page
- 14
- Companies
- 9
All medicines with Chlorothiazide
Human medicines from every register that match Chlorothiazide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
47 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Chlorothiazide | United States | 250MG, 500MG | tablet | Not marketed | Watson Labs |
| Chlorothiazide Sodium | United States | 500MG BASE/VIAL | injectable | Marketed | Am Regent |
| Chlorothiazide-ReserpineCombination | United States | 250MG; 0.125MG, 500MG; 0.125MG | tablet | Not marketed | Pharmobedient |
| Chlorothiazide W/ ReserpineCombination | United States | 250MG; 0.125MG, 500MG; 0.125MG | tablet | Not marketed | Watson Labs |
| Chlorothiazide and ReserpineCombination | United States | 250MG; 0.125MG, 500MG; 0.125MG | tablet | Not marketed | Hikma |
| Methyldopa and ChlorothiazideCombination | United States | 150MG; 250MG, 250MG; 250MG | tablet | Not marketed | Par Pharm |
| Diuril | United States | 250MG/5ML | suspension | Not marketed | Salix Pharms |
| Aldoclor-150Combination | United States | 150MG; 250MG | tablet | Not marketed | Merck |
| Aldoclor-250Combination | United States | 250MG; 250MG | tablet | Not marketed | Merck |
| Diupres-250Combination | United States | 250MG; 0.125MG | tablet | Not marketed | Merck |
| Diupres-500Combination | United States | 500MG; 0.125MG | tablet | Not marketed | Merck |
| Diuril | United States | 250MG, 500MG | tablet | Not marketed | Rising |
| Diuril | United States | 500MG BASE/VIAL | injectable | Not marketed | Rising |
| Hydrochlorothiazide | United States | 12.5MG | capsule | Marketed | Ipca Labs LTD |
| Hydrochlorothiazide | United States | 100MG, 12.5MG, 25MG … | tablet | Marketed | Watson Labs |
| Biomed | New Zealand | Oral liq 50 mg per ml | Funded | ||
| Hydrochlorothiazide | Canada | 25 MG | Tablet | Marketed | Pro Doc Limitee |
| Hydrochlorothiazide | Canada | 25 MG | Tablet | Marketed | Sanis Health INC |
| Hydrochlorothiazide | Canada | 50 MG | Tablet | Authorised | Pro Doc Limitee |
| Hydrochlorothiazide | Canada | 12.5 MG | Tablet | Authorised | Sanis Health INC |
| Apo-Hydrochlorothiazide | Canada | 25 MG | Tablet | Marketed | Apotex INC |
| Apo-Hydrochlorothiazide | Canada | 50 MG | Tablet | Marketed | Apotex INC |
| Apo-Hydrochlorothiazide | Canada | 12.5 MG | Tablet | Marketed | Apotex INC |
| PMS-Hydrochlorothiazide | Canada | 12.5 MG | Tablet | Marketed | Pharmascience INC |
| PMS-Hydrochlorothiazide | Canada | 25 MG | Tablet | Marketed | Pharmascience INC |



